Blumenfeld AM, Boinpally R, De Abreu Ferreira R, Trugman JM, et al. Phase Ib, open-label, fixed-sequence, drug-drug interaction, safety, and tolerability study between atogepant and ubrogepant in participants with a history of migraine. Headache 2023 Jan 5. doi: 10.1111/head.14433.
PMID: 36602199